WuXi Biologics Competitors and Similar CompaniesClear all

WuXi Biologics's competitors and similar companies include Evotec, Lonza, Samsung Biologics and Fujifilm Diosynth Biotechnologies.
WuXi Biologics
WuXi Biologics
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
Evotec
Evotec
Evotec is a biotechnology company that provides drug discovery and development services.
Lonza
Lonza
Lonza Group is a company specializing in life sciences and biotechnology solutions
Samsung Biologics
Samsung Biologics
Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization.
Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.
Founding Date
Founding Date
2010
Founding Date
1993
Founding Date
1897
Founding Date
2011
Founding Date
2011
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Wuxi, CN HQ
George Town, KY
Wuppertal, DE
Hong Kong, HK
Dundalk, IE
Cranbury, US
King Of Prussia, US
Locations
Hamburg, DE HQ
Lyon, FR
Toulouse, FR
Göttingen, DE
Halle (Westfalen), DE
Köln, DE
Munich, DE
see more
Locations
Basel, CH HQ
Baulkham Hills, AU
Antwerpen, BE
Bornem, BE
Verviers, BE
Rio De Janeiro, BR
Dorval, CA
see more
Locations
Incheon, KR HQ
Boston, US
Ridgefield Park, US
South San Francisco, US
Locations
Morrisville, US HQ
Hillerød, DK
Stockton On Tees, GB
College Station, US
Employees
Employees
12,575
Employees
4,766
Employees
19,7712% increase
Employees
4,770
Employees
5,3942% increase

Financial

Revenue (est.)
Revenue (est.)
¥21.8b (FY, 2025)
Revenue (est.)
€788.4m (FY, 2025)
Revenue (est.)
CHF6.5b (FY, 2025)
Revenue (est.)
₩4.6t (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
¥10b (FY, 2025)
Cost of goods
€622.9m (FY, 2025)
Cost of goods
CHF2.1b (FY, 2025)
Cost of goods
₩1.4t (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
¥12b (FY, 2025)
Gross profit
€231.1m (FY, 2025)
Gross profit
CHF4.5b (FY, 2025)
Gross profit
₩3.1t (FY, 2025)
Gross profit
N/A
Net income
Net income
¥5.7b (FY, 2025)
Net income
(€103.5m) (FY, 2025)
Net income
CHF909m (FY, 2025)
Net income
₩1.6t (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 993.6m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 850m
For sources of this data, please see the company profile

View Company Profiles

Evotec
HQ
Hamburg, DE
Employees
4,766

Evotec is a biotechnology company that provides drug discovery and development services.

View company
Lonza
HQ
Basel, CH
Employees
19,771↑ 2% increase

Lonza Group is a company specializing in life sciences and biotechnology solutions

View company
Samsung Biologics
HQ
Incheon, KR
Employees
4,770

Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization.

View company
Fujifilm Diosynth Biotechnologies
HQ
Morrisville, US

Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.

View company